Table 3.

Survival rates reported in literature for various treatment modalities for hepatocellular carcinoma [16–22]

Treatment	Survival rate
	12 months	24 months	36–60 months
PEI [19]			81.6–60.3
RFA [18]	73.9	52.1	71.0–48.0
TACE [20]	97.0	89.0	40.7
TACE + PEI [21]	61.5	38.7
TACE + RFA [22]	89.7	67.1
Wedge resection [16]	88.1	60.1	35.8
Transplant [14]	90	85

Key: RFA = radiofrequency ablation; PEI = percutaneous ethanol injection; TACE = transcatheter arterial chemoembolization.